TRENTON, N.J. (AP) — The Food and Drug Administration said Wednesday that it has approved the first tablet in the U.S. for gradually reducing hay fever symptoms, an alternative to months of weekly doctor visits for uncomfortable allergy-desensitizing shots.
Oralair was approved for patients ages 10 through 65. It’s made by France’s Stallergenes SA, a leader in immunotherapy medicines that dissolve under the tongue.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.